Jeff L Vacirca insider trades

Open-market stock purchases and sales by Jeff L Vacirca, Director at Caris Life Sciences, Inc, from SEC Form 4 filings since Dec 12, 2017.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +98%.

Recent trades

DateStockTradeValue
Aug 14, 2026CAI Caris Life Sciences, IncBought (not open market)—
May 11, 2026CAI Caris Life Sciences, IncBought$501K
Feb 26, 2026CAI Caris Life Sciences, IncBought (not open market)$50K

Companies traded

  • CAI Caris Life Sciences, Inc: 1 buy, last Aug 14, 2026
  • ASRT Assertio Holdings, Inc: 1 buy, last Jun 11, 2024
  • SPPI Spectrum Pharmaceuticals Inc: 1 buy, last Jul 31, 2023
  • ODT Odonate Therapeutics, Inc: 2 buys, last Jun 26, 2019

Get free alerts when Jeff L Vacirca files a new trade →